All Outputs (2)

Building BORIS – an outreach project on drug design and molecular modelling (2017)
Journal Article
Rossington, S. (2017). Building BORIS – an outreach project on drug design and molecular modelling. ˜The œbiochemist (London. Online), 39(2), 50-51. https://doi.org/10.1042/bio03902050

Within university chemistry departments, organic chemists are formulating reaction pathways which will yield a desired chemical product. In most cases, it is often found that the targeted product exerts some beneficial biological effect towards cellu... Read More about Building BORIS – an outreach project on drug design and molecular modelling.

Tubulin-binding dibenz[c,e]oxepines: Part 2 Structural variation and biological evaluation as tumour vasculature disrupting agents (2017)
Journal Article
Hadfield, J., Rossington, S., Wallace, T., Shnyder, S., & Williams, K. (2017). Tubulin-binding dibenz[c,e]oxepines: Part 2 Structural variation and biological evaluation as tumour vasculature disrupting agents. Bioorganic and Medicinal Chemistry, 25(5), 1630-1642. https://doi.org/10.1016/j.bmc.2017.01.027

5,7-Dihydro-3,9,10,11-tetramethoxybenz[c,e]oxepin-4-ol 1, prepared from a dibenzyl ether precursor via Pd-catalysed intramolecular direct arylation, possesses broad-spectrum in vitro cytotoxicity towards various tumour cell lines, and induces vascul... Read More about Tubulin-binding dibenz[c,e]oxepines: Part 2 Structural variation and biological evaluation as tumour vasculature disrupting agents.